Immunology science has achieved what would have been unimaginable just a year ago. Less than 12 months after the WHO declared COVID-19 a pandemic, scientists developed, clinically tested and obtained regulatory approval for vaccines that are remarkably protective against COVID-19. Moreover, real-world data shows that these vaccines are more protective than anticipated based on clinical trial results.  

In a field where innovations are scarce, and the success rate is low, the fact that several vaccines have been approved in multiple countries is a scientific breakthrough. This was made possible because of major advances in scientific knowledge by the time the pandemic hit. Key discoveries in the mechanisms of antigen presentation, adaptive immunity, and drug delivery permitted the development of several vaccine strategies, all of which are protecting against severe COVID-19.

The swiftness of the vaccine effort was also made possible thanks to the work of Chinese scientists who isolated the virus that caused the pandemic and identified its genomics sequence enabling scientists across the world to start the vaccine development process. 

While scientists have done their share and identified a path forward to stop the pandemic, government leaders are struggling to complete theirs.  The pandemic continues to rage in many countries, where vaccines are nowhere to be found.  Wealthy and middle-income countries have purchased 85% of the vaccine doses, while the world's poorest nations may not be able to vaccinate their populations until 2023. These numbers are frightening for both humanitarian and selfish reasons. Humanitarian reasons because the countries with the most vaccine shortages are often those with the most vulnerable healthcare systems, putting their population at higher risk of suffering and death. Selfish reasons because viral spreads also increase the likelihood of the virus mutating and becoming resistant to current vaccines, endangering people worldwide -- including vaccinated ones --. 

Thus government leaders must act swiftly and creatively to enforce the path paved forward by scientists. In addition, leading officials must enhance the manufacture and distribution of vaccines equitably throughout the globe before the virus evolves in a way that fatally undermines the scientific prowess of this past year.

The overall purpose of this consultation is to understand better the gaps, barriers and priorities in the research and innovation of veterinary vaccines globally. This consultation will help inform future veterinary vaccinology strategy. 
The survey report will be published on the UKRI website. In addition, the report will be made available to other research funders for further dissemination.
This survey comprises 47 questions, but you will not be required to answer all the questions. It will take approximately 30 minutes to complete the survey. We thank you in advance for your input.

All information submitted to UKRI-BBSRC will be treated in confidence. However, non-attributable comments from the survey comments may be used in subsequent activities, e.g., included in internal and external publications on this topic.

To complete the survey, please see: 
 

1. To bring together and promote close contact between all people interested in the subject of immunology in Ghana.
2. To provide a platform for discussions of topics relevant to immunology through the organisation of seminars, meetings, workshops, exhibitions, lectures and publications, and to facilitate the exchange of ideas and experiences between its members and like-minded individuals and institutions in the West African sub-region, in Africa and the world.
3. To undertake such activities as are relevant to promoting interest in immunology amongst members and the Society at large.

The aims of the society are:

Immunopaedia.org.za is the official educational provider of pre-course and online IUIS immunology courses, where we have supported courses in south, west, north and east Africa, Latin America, India and Iran. Immunopaedia is open-access and delivers current educational content to provide frameworks of knowledge to IUIS course participants before they embark on face-to-face courses. Learn with free online courses (Learn More) or by our real-life case studies with immunology explanations and quizzes. Immunopaedia provides summaries of the latest research on SARS-CoV-2 and other immunology topics (Read Summaries).

Immunopaedia, in collaboration with the IUIS and Frontiers in Immunology, has organised a webinar series on various immunology topics (Read our summaries of the webinars).

You can also “meet” prominent immunologists from across the globe either as written or video interviews or get to know our network of early-career immunologists through our Immunopaedia Ambassadors Programme.  

Discover More!

Content Highlights: 

• Read our summaries of concepts shared at the IUIS-ALACI-ACAAI Immuno-Colombia Course themed on "Mechanisms and Approaches to Immunotherapy for Cancer and Chronic Inflammatory Diseases”. 
• Immunopaedia Ambassadors celebrate the Day of Immunology
• Course Registrations

Please use this form to submit a career opportunity.

Copyright © 2021 IUIS, All rights reserved.
You are receiving this email because you are a member of an IUIS member society or have registered interest in receiving IUIS updates.

Address
IUIS Central Office
c/o K.I.T. Group GmbH
Kurfürstendamm 71
10709 Berlin, Germany

info@iuis.org | www.iuis.org
Tel.: +49 30 246 03-0 | Fax: +49 30 246 03-200

Legal Notice    Private Policy

Wish to change how you receive these emails?
You can update your preferences or unsubscribe from this list.